EBR/ONWD (EBR/ONWD)

Euronext Brussels: EBR/ONWD · EUR

€2.23

-0.03 (-1.1%)· Recorded snapshot

Market cap	155M
Revenue (ttm)	8.4M
Net income (ttm)	-45.3M
EPS (ttm)	-€0.85
Shares out	69.5M
Volume	169,991
Beta	0.81

Market data

Price

Recent price action with selectable time range.

Financial snapshot

Revenue (ttm): 8.4M
Net income (ttm): -45.3M
EPS (ttm): -€0.85
Market cap: 155M

Calendar

Next earnings

Upcoming earnings date and setup when available.

Upcoming

DateLoading

Window—

EPS estimate—

Revenue estimate—

Sector percentile context

Refreshed 2026-10-29 19:55 UTC

Forward P/En/a

P25 n/aP50 n/aP75 n/a

Trailing P/En/a

P25 n/aP50 n/aP75 n/a

ROE-90.9

P25 n/aP50 n/aP75 n/a

ROIC-43

P25 n/aP50 n/aP75 n/a

Benchmarks · 1M

All EBR/ONWD indicators

Market & fundamental data

Available fields

185

Groups with data

Currency

EUR

Showing 185 of 185 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Amount currency	EUR
Country	Netherlands
Country code	BE
Earnings date	2026-11-03
Employees	137
Employees change	35
Employees growth	33.89%
Enterprise value	EUR 87.3M
Exchange	Euronext Brussels
Financial currency	EUR
Financial report date	2026-06-30
First seen	2026-05-10
Fiscal year end	December
Founded	2014
Industry	Biotechnology
Is primary listing	Yes
ISIN number	NL0015000HT4
Last earnings date	2026-09-09
Last refreshed	2026-10-29
Market cap	EUR 155M
Next earnings date	2026-11-03
Price	EUR 2.23
Price currency	EUR
Sector	Healthcare
SIC code	3841
Stock price date	2026-10-29
Symbol	ebr/ONWD
Website	https://www.onwd.com

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Earnings yield	-38.14%
EV/Sales	10.58x
FCF / EV yield	-52.3%
FCF yield	-29.71%
Industry P/E	28.77x
P/B ratio	2.18x
P/S ratio	18.62x
Price / tangible book value	2.48x
Sector forward P/E	22.94x
Sector P/E	29.62x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
Gross margin	75.36%
Operating margin	-525.44%
Pretax margin	-532.35%
Profit per employee	EUR -330,445
Revenue per employee	EUR 61,467
ROA	-35.3%
ROA (5Y)	-31.42%
ROCE	-48.88%
ROE	-90.85%
ROE (5Y)	-95.16%
ROIC	-43.04%
SBC / revenue	36.73%
Tax / revenue	5.25%

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
EPS growth quarters	1
EPS growth years	0
Gross profit growth	-30.59%
Gross profit growth (Q)	206.82%
Net income growth years	0
Revenue growth	210.05%
Revenue growth (Q)	253.76%
Revenue growth (QoQ)	-0.87%
Revenue growth 3Y	58.55%
Revenue growth 5Y	48.27%
Revenue growth quarters	4
Revenue growth years	1

Financial statements

Income-statement and cash-flow amounts, totals and per share.

Metric	Value
Capital expenditures	EUR -593,000
Depreciation and amortization	EUR 784,000
EBIT	EUR -44.2M
EBITDA	EUR -43.5M
EPS	EUR -0.85
FCF per share	EUR -0.67
Financing cash flow	EUR 86.6M
Free cash flow	EUR -46.6M
Free cash flow minus SBC	EUR -49.7M
Gross profit	EUR 6.3M
Income taxes	EUR 442,000
Investing cash flow	EUR -53.4M
Net borrowing	EUR -613,000
Net cash flow	EUR -12.2M
Net income	EUR -45.3M
Operating cash flow minus SBC	EUR -49.1M
Operating income	EUR -44.2M
Revenue	EUR 8.4M
Stock-based compensation	EUR 3.1M

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Altman Z-Score	0.35
Book value per share	EUR 1.03
Debt / equity	0.19
Goodwill	EUR 1.8M
Interest coverage	-20.33
Long-term assets	EUR 10.4M
Long-term liabilities	EUR 18.6M
Net cash (debt)	EUR 67.7M
Net cash / market cap	43.19%
Net cash growth	161.75%
Net debt / equity	-0.94
Piotroski F-Score	3
Property, plant and equipment	EUR 981,000
Shareholders' equity	EUR 71.9M
Tangible book value	EUR 63.2M
Tangible book value per share	EUR 0.91
Total assets	EUR 100.3M
Total cash	EUR 81.5M
Total debt	EUR 13.8M
Total liabilities	EUR 28.3M
WACC	9%

Liquidity

Current-asset coverage and working-capital efficiency metrics.

Metric	Value
Asset turnover	0.11
Current assets	EUR 89.9M
Current liabilities	EUR 9.7M
Current ratio	9.23
Inventory turnover	2.52
Net working capital	EUR -1.1M
Quick ratio	8.6
Working capital	EUR 80.1M
Working capital turnover	0.15

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

Metric	Value
Buyback yield / dilution	-8.02%
Shareholder yield	-8.02%

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
150-day SMA	EUR 2.62
1D price change	-1.11%
1M price change	-19.49%
1M total return	-19.49%
1W price change	3.48%
1W total return	3.48%
1Y price change	-46.9%
1Y return CAGR	-46.93%
1Y total return	-46.9%
20-day SMA	EUR 2.33
200-day SMA	EUR 2.97
3M price change	-8.04%
3M total return	-8.04%
3Y price change	-26.89%
3Y return CAGR	-9.91%
3Y total return	-26.89%
50-day SMA	EUR 2.50
50-day SMA vs 200-day SMA	50under200
52-week high	EUR 4.79
52-week high date	2026-01-22
52-week low	EUR 2.02
52-week low date	2026-10-27
5Y price change	-82.5%
5Y return CAGR	-29.43%
5Y total return	-82.5%
6M price change	-20.92%
6M total return	-20.92%
All-time high	EUR 13.28
All-time high date	2021-10-21
All-time low	EUR 1.85
All-time low date	2024-01-19
Average true range (ATR)	EUR 0.10
Average volume	127.8K
Beta (1Y)	0.33
Beta (2Y)	0.56
Beta (5Y)	0.81
Change from 52-week high	-53.44%
Change from 52-week low	10.4%
Change from all-time high	-83.21%
Change from all-time low	20.54%
Change from open	-0.89%
Day's gap	-0.22%
Dollar volume	EUR 379,080
High price	EUR 2.27
Low price	EUR 2.21
Monthly RSI	32.95
Open price	EUR 2.25
Position in 52-week range	36.36%
Previous close	EUR 2.26
Price vs 150-day SMA	-14.76%
Price vs 20-day SMA	-4.25%
Price vs 200-day SMA	-24.81%
Price vs 50-day SMA	-10.66%
Relative volume	1.39
RSI	40.52
Sharpe ratio	-1.3
Sharpe ratio (3Y)	-0
Sharpe ratio (5Y)	-0.26
Sortino ratio	-1.84
Sortino ratio (3Y)	0.1
Sortino ratio (5Y)	-0.33
Volume	170K
Weekly RSI	35.83
YTD price change	-50.28%
YTD total return	-50.28%

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Float	54.7M
Shares change (QoQ)	20.17%
Shares change (YoY)	8.02%
Shares held by insiders	1.06%
Shares held by institutions	20.07%
Shares outstanding	69.5M

Deeper analysis on EBR/ONWD

14 sections in the full report · jump straight to what you need

Forecast

Base and Bull forecast paths with report-date return framing.

→

Valuation

Fair-value bridge, DCF, owner earnings, and peer multiples.

→

Sensitivity

Cost-of-equity and terminal-growth stress table.

→

Risks

Kill scenarios, soft-pass flags, and downside catalysts.

→

Earnings

Next earnings setup and beat / inline / miss thresholds.

→

Position sizing

Entry, exit, conviction, and quarterly monitoring rules.

→

Financials

Revenue, margins, cash flow, and balance-sheet context.

→

Peers

Relative valuation and profitability against the cohort.

→

Moat

Economic-profit evidence and competitive advantage risk.

→

Industry cycle

Sector phase, capital cycle, and secular tailwinds.

→

Frequently asked questions

About this EBR/ONWD report

Is a complete EBR/ONWD research report available?

No complete published report is available for ebr/ONWD (EBR/ONWD) on this page. Market-directory data, when present, is not a substitute for a validated stock analysis.

EBR/ONWD (EBR/ONWD)

Price

Financial snapshot

Fair-value bridge

Latest news · EBR/ONWD

Valuation

Profitability

Balance sheet

Trading

Next earnings

Sector percentile context

All EBR/ONWD indicators

Profile and market data

Valuation

Profitability

Growth

Financial statements

Financial strength

Liquidity

Dividends and buybacks

Performance and technicals

Ownership and float

Deeper analysis on EBR/ONWD

Frequently asked questions